Carregant...
Energy Regulation Mechanism and Therapeutic Potential of Asprosin
Genetic studies of patients with neonatal progeroid syndrome led to the discovery of the novel fasting-induced, glucogenic, and orexigenic hormone named asprosin, the C-terminal cleavage product of profibrillin. Upon secretion, asprosin travels to the liver, where it exerts a glucogenic effect throu...
Guardat en:
| Publicat a: | Diabetes |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085243/ https://ncbi.nlm.nih.gov/pubmed/32198197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dbi19-0009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|